Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Looking for Oncology Payoff, Astellas Makes Hostile Bid for Tarceva Maker OSI

Mar 02 2010

• By PharmAsia News

Related Content

Astellas Signs Strategic Oncology Partnership With Ambit After Medivation Success

Dec 18 2009

Astellas Turns Up Heat On Bid To Acquire CV Therapeutics

Feb 27 2009

Astellas Signs Strategic Oncology Partnership With Ambit After Medivation Success

Dec 18 2009

"A Quantum Leap In Resources": Millennium CEO Dunsire In A Conversation On The Firm's First Year As Part Of Takeda (Part 1 Of 2)

Jul 27 2009

CVT And Gilead Look To Lock Out Astellas With Planned Merger

Mar 15 2009

Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration

Oct 27 2009

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window